panax quinquefolius

Botanicalexperimental

American ginseng is a species of flowering plant in the ivy family Araliaceae. It is native to eastern North America and has been introduced into China. The specific epithet quinquefolius means "five-leaved", which refers to the typical number of leaflets per leaf. It is one of a group of taxa known as "ginseng". — Wikipedia

Clinical trial activity

2 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2001 (NCT00219960)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • panax quinquefolius
  • panax quinquefolius l extract

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00527969Phase 2Jul 1, 2007CV Therapeutics, University of Alberta
NCT00219960Phase 3Apr 1, 2001Government of Ontario, Ontario Ginseng Growers Association, Risk Factor Modification Centre, University of Toronto
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CV TherapeuticsFor profit1112007
Government of OntarioGovernment1012001
Ontario Ginseng Growers AssociationAcademic/Hospital1012001
Risk Factor Modification CentreAcademic/Hospital1112001
University of AlbertaAcademic/Hospital1012007
University of TorontoAcademic/Hospital1012001
6 organizations
Page 1 / 1